VL
Veltex Corporation
VLXC · OTC
$0.05 +0.00% (+$0.00)
1M +14.32%
Market Cap $4.90M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.07
40.3% upside
Current Price
$0.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VLXC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
59 /100
Fair P/S 2.94x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 295.44%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 96.57%
Op. margin 85.32%
FCF margin 39.29%
Quality
16 /100
Poor ROA 86.12%
Asset turnover 0.89x
ROIC 255.95%
Debt
0 /100
High Int. coverage -2.77x
Current ratio 0.21x
Net debt/EBITDA N/A
Stability
26 /100
Unstable Rev. volatility 1,484.26%
EPS volatility 47.56%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VLXC
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Andreas Mauritzson
Employees
1,200
Headquarters
Chicago